The table below shows Adaptive Biotechnologies Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$276.98M
$178.96M
$170.28M
$185.31M
$154.34M
$98.38M
Cost of revenue
$71.36M
$72.08M
$75.55M
$57.91M
$49.30M
$22.53M
Gross profit
-
-
-
-
-
-
R&D
$93.77M
$102.95M
$122.12M
$141.76M
$142.34M
$116.07M
SG&A
ADPT annual revenue (10-K history)
Adaptive Biotechnologies Corp reported annual revenue of $276.98M for fiscal year 2025. That is up 54.8% from $178.96M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $38.45M (FY 2017) to $276.98M. Figures come from the company's audited annual reports as filed with the SEC.
